990 related articles for article (PubMed ID: 19245522)
1. Development and validation of small-diameter vascular tissue from a decellularized scaffold coated with heparin and vascular endothelial growth factor.
Zhou M; Liu Z; Wei Z; Liu C; Qiao T; Ran F; Bai Y; Jiang X; Ding Y
Artif Organs; 2009 Mar; 33(3):230-9. PubMed ID: 19245522
[TBL] [Abstract][Full Text] [Related]
2. [Constructing a small-diameter decellularized vascular graft pre-loaded with bFGF].
Zhou M; Liu C; Wei Z; Liu Z; Jiang X; Qiao T; Ran F
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Mar; 22(3):370-5. PubMed ID: 18396724
[TBL] [Abstract][Full Text] [Related]
3. Tissue-engineered blood vessel graft produced by self-derived cells and allogenic acellular matrix: a functional performance and histologic study.
Yang D; Guo T; Nie C; Morris SF
Ann Plast Surg; 2009 Mar; 62(3):297-303. PubMed ID: 19240529
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of granulocyte-colony stimulating factor on small-diameter heparin immobilized decellularized vascular graft.
Zhou M; Liu Z; Li K; Qiao W; Jiang X; Ran F; Qiao T; Liu C
J Biomed Mater Res A; 2010 Nov; 95(2):600-10. PubMed ID: 20725964
[TBL] [Abstract][Full Text] [Related]
5. Basic fibroblast growth factor coating and endothelial cell seeding of a decellularized heparin-coated vascular graft.
Conklin BS; Wu H; Lin PH; Lumsden AB; Chen C
Artif Organs; 2004 Jul; 28(7):668-75. PubMed ID: 15209861
[TBL] [Abstract][Full Text] [Related]
6. Tissue engineering of small-diameter vascular grafts by endothelial progenitor cells seeding heparin-coated decellularized scaffolds.
Zhou M; Liu Z; Liu C; Jiang X; Wei Z; Qiao W; Ran F; Wang W; Qiao T; Liu C
J Biomed Mater Res B Appl Biomater; 2012 Jan; 100(1):111-20. PubMed ID: 22113845
[TBL] [Abstract][Full Text] [Related]
7. Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model.
Walpoth BH; Zammaretti P; Cikirikcioglu M; Khabiri E; Djebaili MK; Pache JC; Tille JC; Aggoun Y; Morel D; Kalangos A; Hubbell JA; Zisch AH
J Thorac Cardiovasc Surg; 2007 May; 133(5):1163-70. PubMed ID: 17467424
[TBL] [Abstract][Full Text] [Related]
8. Tissue engineering of urethra using human vascular endothelial growth factor gene-modified bladder urothelial cells.
Guan Y; Ou L; Hu G; Wang H; Xu Y; Chen J; Zhang J; Yu Y; Kong D
Artif Organs; 2008 Feb; 32(2):91-9. PubMed ID: 18005271
[TBL] [Abstract][Full Text] [Related]
9. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
[TBL] [Abstract][Full Text] [Related]
10. The development of a tissue-engineered artery using decellularized scaffold and autologous ovine mesenchymal stem cells.
Zhao Y; Zhang S; Zhou J; Wang J; Zhen M; Liu Y; Chen J; Qi Z
Biomaterials; 2010 Jan; 31(2):296-307. PubMed ID: 19819544
[TBL] [Abstract][Full Text] [Related]
11. Decellularized and photooxidatively crosslinked bovine jugular veins as potential tissue engineering scaffolds.
Lü WD; Zhang M; Wu ZS; Hu TH
Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):301-5. PubMed ID: 19074454
[TBL] [Abstract][Full Text] [Related]
12. Tubular nanofiber scaffolds for tissue engineered small-diameter vascular grafts.
He W; Ma Z; Teo WE; Dong YX; Robless PA; Lim TC; Ramakrishna S
J Biomed Mater Res A; 2009 Jul; 90(1):205-16. PubMed ID: 18491396
[TBL] [Abstract][Full Text] [Related]
13. Vascular tissue generation in response to signaling molecules integrated with a novel poly(epsilon-caprolactone)-fibrin hybrid scaffold.
Pankajakshan D; Krishnan V K; Krishnan LK
J Tissue Eng Regen Med; 2007; 1(5):389-97. PubMed ID: 18038433
[TBL] [Abstract][Full Text] [Related]
14. Gradient nanofibrous chitosan/poly ɛ-caprolactone scaffolds as extracellular microenvironments for vascular tissue engineering.
Du F; Wang H; Zhao W; Li D; Kong D; Yang J; Zhang Y
Biomaterials; 2012 Jan; 33(3):762-70. PubMed ID: 22056285
[TBL] [Abstract][Full Text] [Related]
15. Decellularized vein as a potential scaffold for vascular tissue engineering.
Schaner PJ; Martin ND; Tulenko TN; Shapiro IM; Tarola NA; Leichter RF; Carabasi RA; Dimuzio PJ
J Vasc Surg; 2004 Jul; 40(1):146-53. PubMed ID: 15218475
[TBL] [Abstract][Full Text] [Related]
16. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF.
Nillesen ST; Geutjes PJ; Wismans R; Schalkwijk J; Daamen WF; van Kuppevelt TH
Biomaterials; 2007 Feb; 28(6):1123-31. PubMed ID: 17113636
[TBL] [Abstract][Full Text] [Related]
17. Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration.
Leach JK; Kaigler D; Wang Z; Krebsbach PH; Mooney DJ
Biomaterials; 2006 Jun; 27(17):3249-55. PubMed ID: 16490250
[TBL] [Abstract][Full Text] [Related]
18. The in vitro and in vivo biocompatibility evaluation of heparin-poly(ε-caprolactone) conjugate for vascular tissue engineering scaffolds.
Ye L; Wu X; Duan HY; Geng X; Chen B; Gu YQ; Zhang AY; Zhang J; Feng ZG
J Biomed Mater Res A; 2012 Dec; 100(12):3251-8. PubMed ID: 22733560
[TBL] [Abstract][Full Text] [Related]
19. A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: excellent 6-month patency.
Ishii Y; Sakamoto S; Kronengold RT; Virmani R; Rivera EA; Goldman SM; Prechtel EJ; Hill JG; Damiano RJ
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1237-45; discussion 1245-6. PubMed ID: 18544361
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of in vivo endothelialization of tissue-engineered vascular grafts by granulocyte colony-stimulating factor.
Cho SW; Lim JE; Chu HS; Hyun HJ; Choi CY; Hwang KC; Yoo KJ; Kim DI; Kim BS
J Biomed Mater Res A; 2006 Feb; 76(2):252-63. PubMed ID: 16265638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
